Advertisement
Screener

LARIMAR THERAPEUTICS, INC. (LRMR) Cash Flow Breakdown

LARIMAR THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where LARIMAR THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $113.20M went out.
  • Fiscal year ended 2025-12-31: from investing, $100.31M came in.
  • Fiscal year ended 2025-12-31: from financing, $65.09M came in.
  • Fiscal year ended 2025-12-31: change in cash, $52.19M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$113.20M$100.31M$65.09M$52.19M
2024-12-31-$70.76M-$85.39M$161.81M$5.74M
2023-12-31-$33.46M$33.35M-$76.00K
2022-12-31-$27.57M-$90.96M$75.26M-$43.27M
2021-12-31-$42.10M$24.17M$19.89M$1.95M
2020-12-31-$42.20M$17.09M$75.59M$18.00M*$68.48M
2019-12-31-$22.70M-$83.00K$19.39M*-$3.39M
2018-12-31-$51.49M-$6.87M$64.86M$2.05M*$8.55M
2017-12-31-$43.78M$35.65M$16.56M*$8.43M
2016-12-31-$51.98M$51.45M-$2.71M*-$3.24M
2015-12-31-$59.55M-$92.12M$130.04M-$880.00K*-$22.51M
2014-12-31-$28.24M-$57.31M$102.67M$5.47M*$22.59M
2013-12-31-$15.00M-$17.00K$40.60M*$25.58M
2012-12-31-$13.59M-$2.00K$13.00K$22.05M*$8.47M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$44.03M*-$40.91M*
2026-03-31-$44.61M$29.00M$108.11M*$92.50M
2025-06-30-$19.38M*$18.84M*
2025-03-31-$26.54M$14.45M-$12.09M
2024-12-31-$21.82M*$19.20M*$0.00*
2024-09-30-$24.55M*$27.27M*
2024-06-30-$13.99M*-$63.49M*
2024-03-31-$10.41M-$68.36M$162.15M*$83.38M
2023-12-31-$9.34M*-$2.63M*
2023-09-30-$9.20M*-$46.43M*
2023-06-30-$7.37M*-$9.84M*
2023-03-31-$7.55M$92.25M$84.70M
2022-12-31-$6.67M*-$52.23M*
2022-09-30-$5.88M*-$3.38M*
2022-06-30-$7.49M*
2022-03-31-$7.53M-$7.53M
2021-12-31-$7.92M*$6.49M*$0.00*
2021-09-30-$12.20M*-$6.79M*
2021-06-30-$10.78M*$19.22M*
2021-03-31-$11.21M$5.25M-$5.96M
2020-12-31-$9.86M*-$23.55M*$242.00K*
2020-09-30-$11.22M*-$8.00K*-$135.00K*
2020-06-30-$12.20M*$41.42M*$83.90M*
2020-03-31-$8.92M-$778.00K$9.58M*-$122.00K
2019-12-31-$7.91M*-$50.00K*$3.46M*
2019-09-30-$5.82M*$0.00*$9.95M*
2019-06-30$3.51M*-$840.00K*$5.89M*
2019-03-31-$12.47M$807.00K-$11.57M
2018-12-31-$11.83M*$14.27M*$1.76M*$4.19M*
2018-09-30-$13.08M*-$47.44M*$64.91M*$4.40M*
2018-06-30-$13.31M*$8.34M*-$4.99M*
2018-03-31-$13.27M$17.96M$4.95M
2017-12-31-$9.84M*$12.69M*$18.73M*$21.58M*
2017-09-30-$12.09M*$279.00K*-$724.00K*-$12.53M*
2017-06-30-$10.18M*$13.99M*-$712.00K*$3.09M*
2017-03-31-$11.68M$8.69M-$732.00K*-$3.72M
2016-12-31-$8.67M*$16.91M*-$756.00K*$7.49M*
2016-09-30-$11.03M*$16.44M*-$576.00K*$4.83M*
2016-06-30-$14.52M*$3.82M*-$726.00K*-$11.42M*
2016-03-31-$17.76M$14.27M-$657.00K*-$4.14M
2015-12-31-$17.94M*$15.46M*$0.00*-$684.00K*-$3.17M*
2015-09-30-$16.14M*-$28.51M*$0.00*-$44.81M*
2015-06-30-$14.39M*-$9.34M*$0.00*-$23.36M*
2015-03-31-$11.09M-$69.73M$130.04M$48.83M
2014-12-31-$11.71M*-$57.22M*-$68.93M*
2014-09-30-$6.28M*-$31.00K*-$894.00K*-$7.20M*
2014-06-30-$6.23M*-$63.00K*$102.04M*$95.75M*
2014-03-31-$4.02M-$5.00K$6.99M*$2.97M
2013-12-31-$4.13M*-$8.00K*$34.81M*$30.67M*
2013-09-30-$3.44M*-$1.00K*-$3.61M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
Vogenx, Inc. (VOGX)United States$0.355B
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58